UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE

UTOPIA aims to carry out Seed and Series A operations in the Life Sciences sector, an industry with significant investment opportunities. In Italy, it is still relatively underrepresented and characterized by a gap in terms of VC investments compared to the leading countries of the European Union.

OUR FOCUS

  • DISEASE MODIFYING DRUGS
  • CROSS BORDER CON ARTIFICIAL INTELLIGENCE
  • MEDICAL DEVICES
  • DIAGNOSTIC TOOLS AND BIOMARKERS

OUR INVESTMENTS

  • Novavido Srl
  • PerFormS Srl 
  • Lighthouse Biotech Srl 
  • Drug Discovery and Clinic Srl
  • CaSRevolution Srl
  • T-One Therapeutics Srl

The promoting members

UTOPIA SIS S.p.A.

UTOPIA SOCIETA’ DI INVESTIMENTO SEMPLICE aims to carry out Seed and Series A operations in the Life Sciences sector, an industry with significant investment opportunities. In Italy, it is still relatively underrepresented and characterized by a gap in terms of VC investments compared to the leading countries of the European Union.

What is a SIS

SOCIETA’ DI INVESTIMENTO SEMPLICE (SIS) is a Venture Capital vehicle aimed at investing in start-ups and unlisted SMEs and subject to a subsidized regime.

 

Our Focus

I

DISEASE MODIFYING DRUGS

I

CROSS BORDER CON ARTIFICIAL INTELLIGENCE

I

MEDICAL DEVICES

I

DIAGNOSTIC TOOLS AND BIOMARKERS

Latest News

Utopia SIS and Pariter Partners invest in Lighthouse Biotech

Utopia SIS and Pariter Partners invest in Lighthouse Biotech

Lighthouse Biotech aims to define new boundaries for oncology research through new liquid biopsy technologies The investment will be the first to be guaranteed by Medio Credito Centrale for over 80% Milan, December 29, 2021 - Utopia SIS, an investment company...

WordPress Cookie Plugin by Real Cookie Banner